Table 1 Expression of IMP3 in patients with lung adenocarcinoma
From: IMP3 can predict aggressive behaviour of lung adenocarcinoma
Variable |  | N | IMP3 (N = 90) | P | |
|---|---|---|---|---|---|
| Â | Â | Â | Negative N (%) | Positive N (%) | Â |
Gradus | 1 | 18 | 8 (29.6) | 10 (15) | 0.287 |
| Â | 2 | 23 | 7 (25.9) | 16 (25) | Â |
| Â | 3 | 49 | 12 (44) | 37 (58) | Â |
Subtype | solid | 52 | 9 (33) | 43 (68) | 0.002 |
| Â | others | 38 | 18 (66) | 20 (31) | Â |
Napsin A | negative/light | 60 | 12 (46) | 48 (77) | 0.004 |
| Â | strong positive | 28 | 14 (53) | 14 (22) | Â |
TTF-1 | negative | 31 | 9 (33.3) | 22 (39.2) | 0.599 |
| Â | positive | 52 | 18 (66.6) | 34 (60.7) | Â |
Pleural effusion | no | 29 | 6 (42.8) | 3 (76.6) | 0.063 |
| Â | yes | 15 | 8 (16.6) | 7 (23.3) | Â |
T staging | 2 | 10 | 4 (33.3) | 6 (21.4) | 0.458 |
| Â | 3 | 10 | 2 (16.6) | 8 (28.5) | Â |
| Â | 4 | 20 | 6 (50) | 14 (50) | Â |
N staging | 1 | 20 | 9 (64) | 11 (52.3) | 0.612 |
| Â | 2 | 14 | 5 (35) | 9 (42.8) | Â |
| Â | 3 | 1 | 0 | 1 (4) | Â |
M staging | 0 | 31 | 10 (37) | 22 (34.9) | 0.033 |
| Â | 1a | 14 | 8 (29.6) | 6 (9.5) | Â |
| Â | 1b | 45 | 9 (33.3) | 36 (55.5) | Â |